Published May 28, 2020
| Version v1
Patent
Open
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
- 1. University of Chicago
- 2. Salix Pharmaceuticals
Contributors
Patent applicants:
Description
Presented herein are methods for preventing or treating tumor growth, tumor metastasis and/or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.
Files
US20200163958.pdf
Files
(3.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:a0223903715c6b0ccf369758ac28bbd6
|
3.2 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201916667300 A
- Patent number
- US 2020/0163958 A1
- Other
- oai:uchicago.tind.io:9483
Dates
- Patent filed
-
2019-10-29